Putting Science to Work

Archives / 2018 / November

  • Syngene International net up by 1.7% in Q2

    PharmaBiz- 25/10/2018. Both our Discovery Services and Dedicated Centre verticals performed well, with the later benefiting from expansions announced earlier in the year of our collaboration with Baxter.

    .

Discovery Chemistry Discovery Biology Safety Assessment Large Molecule Development Chemical Development Formulation Development Stability Studies Polymer Research Integrated Discovery & Development Clinical Development Services Bioinfomatics Antibody Drug Conjugates Oligonucleotide Synthesis Contact Us

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

Social Widget